These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 7511740

  • 1. Effects of angiotensin-converting enzyme inhibitors on glucose and lipid metabolism in essential hypertension.
    Oksa A, Gajdos M, Fedelesová V, Spustová V, Dzúrik R.
    J Cardiovasc Pharmacol; 1994 Jan; 23(1):79-86. PubMed ID: 7511740
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Lisinopril is neutral to insulin sensitivity and serum lipoproteins in essential hypertensive patients.
    Thürig C, Böhlen L, Schneider M, de Courten M, Shaw SG, Riesen W, Weidmann P.
    Eur J Clin Pharmacol; 1995 Jan; 49(1-2):21-6. PubMed ID: 8751016
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Glucose and lipid metabolism in essential hypertension: effects of diuretics and ACE-inhibitors.
    De Cesaris R, Ranieri G, Filitti V, Andriani A, Lamontanara G.
    Cardiology; 1993 Jan; 83(3):165-72. PubMed ID: 8281530
    [Abstract] [Full Text] [Related]

  • 7. Glucose and lipid metabolism during long-term treatment with cilazapril in hypertensive patients with or without impaired glucose metabolism.
    Shionoiri H, Sugimoto K, Minamisawa K, Ueda S, Ebina T, Matsukawa T, Gotoh E, Ishii M.
    J Cardiovasc Pharmacol; 1990 Jun; 15(6):933-8. PubMed ID: 1694916
    [Abstract] [Full Text] [Related]

  • 8. Comparison of rilmenidine and lisinopril on ambulatory blood pressure and plasma lipid and glucose levels in hypertensive women with metabolic syndrome.
    Anichkov DA, Shostak NA, Schastnaya OV.
    Curr Med Res Opin; 2005 Jan; 21(1):113-9. PubMed ID: 15881482
    [Abstract] [Full Text] [Related]

  • 9. Effect of cilazapril therapy on glucose and lipid metabolism in patients with hypertension.
    Shionoiri H, Takasaki I, Naruse M, Nagamoti I, Himeno H, Ito T, Ohtomi S, Hata T, Shindo K, Mikami H.
    Clin Ther; 1995 Jan; 17(6):1126-35. PubMed ID: 8750404
    [Abstract] [Full Text] [Related]

  • 10. Lymphocyte-suppressing action of angiotensin-converting enzyme inhibitors in coronary artery disease patients with normal blood pressure.
    Krysiak R, Okopień B.
    Pharmacol Rep; 2011 Jan; 63(5):1151-61. PubMed ID: 22180357
    [Abstract] [Full Text] [Related]

  • 11. Clinical acceptability of ACE inhibitor therapy in mild to moderate hypertension, a comparison between perindopril and enalapril.
    Alcocer L, Campos C, Bahena JH, Nacaud A, Parra Carillo J, Calvo C, Weber C, Lerebours G, Mickalonis L, Villahermosa MT.
    Cardiovasc Drugs Ther; 1995 Jun; 9(3):431-6. PubMed ID: 8527353
    [Abstract] [Full Text] [Related]

  • 12. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
    Hakamäki T, Lehtonen A.
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group.
    Grimm RH, Flack JM, Grandits GA, Elmer PJ, Neaton JD, Cutler JA, Lewis C, McDonald R, Schoenberger J, Stamler J.
    JAMA; 1997 Jun; 275(20):1549-56. PubMed ID: 8622245
    [Abstract] [Full Text] [Related]

  • 15. [Effect of angiotensin converting enzyme inhibitors on lipid, purine and glucose metabolism].
    Buemi M, Frisina N.
    Recenti Prog Med; 1989 Feb; 80(2):78-82. PubMed ID: 2540515
    [Abstract] [Full Text] [Related]

  • 16. Effects of chronic angiotensin converting enzyme inhibition on glucose tolerance and insulin sensitivity in essential hypertension.
    Santoro D, Natali A, Palombo C, Brandi LS, Piatti M, Ghione S, Ferrannini E.
    Hypertension; 1992 Aug; 20(2):181-91. PubMed ID: 1639459
    [Abstract] [Full Text] [Related]

  • 17. Influence of ACE inhibition on glucose tolerance in patients with stable chronic renal failure.
    Fliser D, Rett K, Hübinger A, Ritz E.
    Nephrol Dial Transplant; 1995 Aug; 10(5):643-7. PubMed ID: 7566576
    [Abstract] [Full Text] [Related]

  • 18. Insulin sensitivity in obese hypertensive dyslipidemic patients treated with enalapril or atenolol.
    Morel Y, Gadient A, Keller U, Vadas L, Golay A.
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):306-11. PubMed ID: 7475056
    [Abstract] [Full Text] [Related]

  • 19. Effects of perindopril on glucose and lipid metabolism in patients with mild-to-moderate essential hypertension and glucose intolerance.
    Uchida K, Azukizawa S, Kigoshi T, Nakano S, Kaneko M, Morimoto S, Matsui A.
    Clin Ther; 1994 Aug; 16(3):466-70. PubMed ID: 7923313
    [Abstract] [Full Text] [Related]

  • 20. Effects of perindopril on carbohydrate and lipoprotein metabolism in essential hypertension.
    Giuntoli F, Gabbani S, Natali A, Galeone F, Saba P.
    Am J Med; 1992 Apr 27; 92(4B):95S-97S. PubMed ID: 1580289
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.